Study type

Study type

Non-interventional study

Scope of the study

Disease epidemiology
Non-interventional study

Non-interventional study design

Cross-sectional
Study drug and medical condition

Medical condition to be studied

Asthma
Population studied

Age groups

Adults (18 to < 46 years)
Adults (46 to < 65 years)
Adults (65 to < 75 years)
Adults (75 to < 85 years)
Adults (85 years and over)

Estimated number of subjects

2000
Study design details

Main study objective

The study aims to describe and compare the demographic and clinical features of early-onset vs late-onset asthma phenotypes in an international cohort of adult patients with severe asthma.

Outcomes

The primary outcome is to describe the distribution of age of asthma onset in the international severe asthma cohort, define and validate the most appropriate age cut-off to delineate age-of-onset groups and to describe and compare the demographic and clinical characteristics of the early-onset vs late-onset asthma phenotypes in adult patients with severe asthma. The secondary outcome is to evaluate possible geographical differences in early-onset and late-onset asthma phenotypes in a severe asthma population.

Data analysis plan

To define age cut-off, the study will explore the potential cut-offs through various methods including ROC curve analysis and best fitted model (highest area under the curve). Baseline characteristics will be reported for early-onset and late-onset asthma groups with continuous variables summarised using descriptive statistics, the frequency and percentages of observed levels will be reported for categorical variables, and tables will be annotated with the total population size. Characteristics of groups will be compared via contingency tables and group difference will be tested for statistical significance via chi-square tests for comparison of counts. Moreover, t-test or one-way analysis of variance (ANOVA) will be applied to compare means across groups. Demographic or clinical constructs will be compared between early-onset vs late-onset severe asthma phenotype groups.